Curative Locoregional Therapy following Objective Response to Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Overview & Synopsis
Open access biomedical research article published in Liver Cancer.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Curative Locoregional Therapy following Objective Response to Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. |
|---|---|
| Author / Organization | Shao YY, Chen SC, Rau KM, Lee TY, Chan SL, Liu K, Lai HC, George J, Gofton C, Putraveephong S, Feng YH, Lee MY, Lee JX, Tai D, Lee SY, Chen YH, Wu TC, Mo LR, Wi WZ, Lesmana CRA, Hui CV, Li SSS, Hasan I, Chan LL, Nguyen M, De Silva M, Chuang CH |
| Subject & Discipline | Liver Cancer |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-54180 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |